PCSA - Processa Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development3,085.317964.1641,536.9963
Selling General and Administrative1,295.623779.506384.524254.115
Non Recurring----
Others----
Total Operating Expenses4,380.941,743.671,921.52257.115
Operating Income or Loss-4,380.94-1,743.67-1,921.52-257.115
Income from Continuing Operations
Total Other Income/Expenses Net-286.908-112.6454.454-
Earnings Before Interest and Taxes-4,380.94-1,743.67-1,921.52-257.115
Interest Expense-161.205-59.063-59.063-59.063
Income Before Tax-4,667.848-1,856.315-1,917.066-257.115
Income Tax Expense-902.801---
Minority Interest----
Net Income From Continuing Ops-3,765.047-1,856.315-1,917.066-257.115
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,765.047-1,856.315-1,917.066-257.115
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-3,765.047-1,856.315-1,917.066-257.115